Top Markets
Coin of the day
Quantumzyme Corp. Quantumzyme Corp.

Quantumzyme Corp.

QTZM
Rank in Stocks #31259
Quantumzyme Corp. is a biotransformation firm specializing in the creation of... Quantumzyme Corp. is a biotransformation firm specializing in the creation of engineered enzymes, primarily utilized for the production of active pharmaceutical ingredients (APIs). Established in 2015, the company was formerly known as Reliant Services, Inc. until it rebranded as Quantumzyme Corp. in March 2023. Its operations are headquartered in San Diego, California.
Share Price
$0.39
Last synced: 2026-03-23
Market Cap
$13.78M
Change (1 day)
225.00%
Change (1 year)
143.29%
Country
US
Trade Quantumzyme Corp. (QTZM)
P/E ratio for Quantumzyme Corp. (QTZM)
P/E ratio as of 2026 TTM: 0
According to Quantumzyme Corp. latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for Quantumzyme Corp. from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
31.02 -
GB
- -
FR
32.79 -
US
36.81 -
US
-1.49K -
US
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.